Shumsky A G, Stuart G C, Nation J
Department of Gynecology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Gynecol Oncol. 1994 Apr;53(1):50-4. doi: 10.1006/gyno.1994.1086.
The purpose of this study was to identify the reasons for treatment failures in patients managed with cervical intraepithelial neoplasia who subsequently developed invasive carcinoma of the cervix. Of 672 patients seen with cervical carcinoma from 1980 to 1990 inclusive, at the Tom Baker Cancer Centre, 24 (3.6%) had previously undergone conservative treatment for CIN and represent the current study population. The initial colposcopic-guided biopsy showed metaplasia (2), CIN 2 (5), and CIN 3 (17). The conservative treatment methods included observation (5), electrocautery (1), laser ablation (3), surgical cone (5), and cryotherapy (10). The mean time interval in months from conservative treatment of CIN to diagnosis of cervical cancer was 21.8 with cryotherapy and 26.7 with laser ablation. The FIGO stage of invasive cervical cancer was Stage 1A (7), Stage 1B (15), Stage 2A (1), and Stage 3 (1). The single death was a patient aged 30 with metastatic small cell cervical carcinoma arising within 4 years of cryotherapy for CIN 3. Of the 24 patients, 13 were managed appropriately yet developed carcinoma, 3 deviated from an accepted standard colposcopy protocol, 5 had inadequate follow-up, 2 refused treatment, and 1 developed de novo disease. The principle reason for treatment failure according to the literature is blatant deviation from protocol. This study, however, suggests that established invasive disease may have gone undetected prior to an ablative therapy. Difficulties related to diagnosis are discussed. The importance of peer reviews becomes evident if practices are to be evaluated and changes to protocols are to be implemented.
本研究的目的是确定那些最初接受宫颈上皮内瘤变治疗但随后发展为宫颈浸润癌的患者治疗失败的原因。在1980年至1990年期间于汤姆·贝克癌症中心就诊的672例宫颈癌患者中,有24例(3.6%)此前曾接受过宫颈上皮内瘤变的保守治疗,这些患者构成了本研究的人群。最初的阴道镜引导下活检显示化生(2例)、宫颈上皮内瘤变2级(CIN 2,5例)和宫颈上皮内瘤变3级(CIN 3,17例)。保守治疗方法包括观察(5例)、电灼术(1例)、激光消融(3例)、手术锥切(5例)和冷冻疗法(10例)。从宫颈上皮内瘤变保守治疗到宫颈癌诊断的平均时间间隔(以月为单位),冷冻疗法为21.8个月,激光消融术为26.7个月。宫颈浸润癌的国际妇产科联盟(FIGO)分期为1A期(7例)、1B期(15例)、2A期(1例)和3期(1例)。唯一的死亡病例是一名30岁的患者,在因CIN 3接受冷冻疗法4年内发生了转移性小细胞宫颈癌。在这24例患者中,13例治疗得当但仍发展为癌症,3例偏离了公认的标准阴道镜检查方案,5例随访不足,2例拒绝治疗,1例发生了新发疾病。根据文献,治疗失败的主要原因是公然违反方案。然而,本研究表明,在进行消融治疗之前,可能未检测到已存在的浸润性疾病。文中讨论了与诊断相关的困难。如果要对医疗实践进行评估并实施方案变更,同行评议的重要性就变得显而易见。